Cite
HARVARD Citation
Hajela, P. et al. (2022). A comparative multi-tiered immunogenicity assessment of biosimilar pegylated filgrastim: validation of methods for clinical assessment of INTP5. Expert opinion on biological therapy. pp. 321-330. [Online].